USA — Janssen Biotech, Inc., an arm of Johnson & Johnson (J&J), has signed a strategic partnership and license deal with Evotec, a German drug maker to develop first-in-class targeted…
Read MoreTag: Johnson & Johnson
J&J experimental HIV vaccine candidate fails in advanced trials
USA — Johnson & Johnson has announced that it was discontinuing a late-stage global trial of an HIV vaccine after it was discovered to be ineffective at preventing infections. The…
Read MoreJ&J’s CEO Joaquin Duato to take an additional role as chairman of board
USA — Johnson & Johnson’s board of directors has elected Chief Executive Officer Joaquin Duato to the additional role of chairman, beginning in January. Alex Gorsky, who will step down…
Read MoreJohnson & Johnson to acquire cardiovascular technology company Abiomed for US$16.6B
USA— Johnson & Johnson (J&J) has struck a deal to buy heart pump maker Abiomed Inc for US$16.6 billion in cash, as it looks to boost growth in its medical…
Read MoreAmref, J&J unite to train oncology nurses amidst ongoing COVID-19 pandemic
KENYA – Amref Health Africa, the largest health development non-governmental international organisation based in Africa, and Johnson & Johnson have partnered to build the capacity of nurses in oncology nursing…
Read MoreFDA approves J&J’s multiple myeloma drug targeting BCMA and CD3 Proteins
USA —The Food and Drug Administration (FDA) has approved Johnson & Johnson’s B-Cell Maturation Antigen-CD3 (BCMA-CD3)-directed bispecific therapy for treating multiple myeloma, giving patients with the incurable blood cancer another…
Read MoreSouth Africa opts out of COVID-19 vaccine contract with Johnson & Johnson
SOUTH AFRICA – The South African Government is considering terminating its COVID-19 vaccine contract with multinational healthcare company Johnson & Johnson (J&J) following late initial deliveries of jabs and current…
Read MoreSouth Africa, ARF, AVATT partner to deliver 2 million doses of Johnson & Johnson vaccines
SOUTH AFRICA – The Government of South Africa, through the African Renaissance Fund (ARF), has teamed up with the African Vaccination Acquisition Trust (AVAT) to contribute a total of 2,030,400…
Read MoreJ&J announces US$5B share repurchase program
USA – Johnson & Johnson has announced a share repurchase program to buy back up to US$5 billion of the company’s common stock. J&J said the repurchase program announced has…
Read MoreBiosense Webster launches mapping catheter for cardiac arrhythmias
USA – Johnson & Johnson’s Biosense Webster has launched the Octaray mapping catheter with TRUEref technology designed for mapping cardiac arrhythmias, including Atrial fibrillation (AFib). It is powered by the…
Read More